PubMed

No effect of statin therapy on silent myocardial ischemia in patients with type 2 diabetes without manifest cardiovascular disease.

Beishuizen ED, Jukema JW, Tamsma JT, van de Ree MA, van der Vijver JC, Putter H, Maan AC, Meinders AE, Huisman MV.

Diabetes Care. 2005 Jul;28(7):1675-9.PMID: 15983319 [PubMed - indexed for MEDLINE]Related articlesFree article

Two-year statin therapy does not alter the progression of intima-media thickness in patients with type 2 diabetes without manifest cardiovascular disease.

Beishuizen ED, van de Ree MA, Jukema JW, Tamsma JT, van der Vijver JC, Meinders AE, Putter H, Huisman MV.

Diabetes Care. 2004 Dec;27(12):2887-92.PMID: 15562202 [PubMed - indexed for MEDLINE]Related articlesFree article

The effect of statin therapy on endothelial function in type 2 diabetes without manifest cardiovascular disease.

Beishuizen ED, Tamsma JT, Jukema JW, van de Ree MA, van der Vijver JC, Meinders AE, Huisman MV.

Diabetes Care. 2005 Jul;28(7):1668-74.PMID: 15983318 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial.

Keech A, Simes RJ, Barter P, Best J, Scott R, Taskinen MR, Forder P, Pillai A, Davis T, Glasziou P, Drury P, Kesäniemi YA, Sullivan D, Hunt D, Colman P, d'Emden M, Whiting M, Ehnholm C, Laakso M; FIELD study investigators.

Lancet. 2005 Nov 26;366(9500):1849-61. Erratum in: Lancet. 2006 Oct 21;368(9545):1415. Lancet. 2006 Oct 21;368(9545):1420. PMID: 16310551 [PubMed - indexed for MEDLINE]Related articles

Silent myocardial ischemia in patients with diabetes: who to screen.

Janand-Delenne B, Savin B, Habib G, Bory M, Vague P, Lassmann-Vague V.

Diabetes Care. 1999 Sep;22(9):1396-400.PMID: 10480499 [PubMed - indexed for MEDLINE]Related articlesFree article

[Factors influencing cardiac complications in patients with type-2 diabetes mellitus and silent myocardial ischaemia: five-year follow-up]

Mamcarz A, Chmielewski M, Braksator W, Syska-Sumńska J, Janiszewski M, Król J, Kuch M, Kuch J, Dłuiniewski M.

Pol Arch Med Wewn. 2004 Dec;112(6):1433-43. Polish. PMID: 15962608 [PubMed - indexed for MEDLINE]Related articles

Efficacy and safety of cerivastatin for type 2 diabetes and hypercholesterolaemia. Hyperlipidaemia in Diabetes Mellitus investigators.

Rubinstein A, Maritz FJ, Soule SG, Markel A, Chajek-Shaul T, Maislos M, Tal S, Stolero D.

J Cardiovasc Risk. 1999 Dec;6(6):399-403.PMID: 10817086 [PubMed - indexed for MEDLINE]Related articles

Effect of fluvastatin on ischaemia following acute myocardial infarction: a randomized trial.

Liem AH, van Boven AJ, Veeger NJ, Withagen AJ, Robles de Medina RM, Tijssen JG, van Veldhuisen DJ; FLuvastatin On Risk Diminishment after Acute myocardial infarction study group.

Eur Heart J. 2002 Dec;23(24):1931-7.PMID: 12473255 [PubMed - indexed for MEDLINE]Related articles

Effect of free fatty acid inhibition on silent and symptomatic myocardial ischemia in diabetic patients with coronary artery disease.

Marazzi G, Wajngarten M, Vitale C, Patrizi R, Pelliccia F, Gebara O, Pierri H, Ramires JA, Volterrani M, Fini M, Rosano GM.

Int J Cardiol. 2007 Aug 9;120(1):79-84. Epub 2006 Nov 28.PMID: 17134770 [PubMed - indexed for MEDLINE]Related articles

Intense cholesterol lowering therapy with a HMG-CoA reductase inhibitor does not improve nitric oxide dependent endothelial function in type-2-diabetes--a multicenter, randomised, double-blind, three-arm placebo-controlled clinical trial.

Balletshofer BM, Goebbel S, Rittig K, Enderle M, Schmölzer I, Wascher TC, Ferenc Pap A, Westermeier T, Petzinna D, Matthaei S, Häring HU.

Exp Clin Endocrinol Diabetes. 2005 Jun;113(6):324-30.PMID: 15977099 [PubMed - indexed for MEDLINE]Related articles

Effects of percutaneous coronary interventions in silent ischemia after myocardial infarction: the SWISSI II randomized controlled trial.

Erne P, Schoenenberger AW, Burckhardt D, Zuber M, Kiowski W, Buser PT, Dubach P, Resink TJ, Pfisterer M.

JAMA. 2007 May 9;297(18):1985-91.PMID: 17488963 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of intensive versus moderate lipid-lowering therapy on myocardial ischemia in older patients with coronary heart disease: results of the Study Assessing Goals in the Elderly (SAGE).

Deedwania P, Stone PH, Bairey Merz CN, Cosin-Aguilar J, Koylan N, Luo D, Ouyang P, Piotrowicz R, Schenck-Gustafsson K, Sellier P, Stein JH, Thompson PL, Tzivoni D.

Circulation. 2007 Feb 13;115(6):700-7. Epub 2007 Feb 5.PMID: 17283260 [PubMed - indexed for MEDLINE]Related articlesFree article

Relation of characteristics of metabolic syndrome to short-term prognosis and effects of intensive statin therapy after acute coronary syndrome: an analysis of the Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) trial.

Schwartz GG, Olsson AG, Szarek M, Sasiela WJ.

Diabetes Care. 2005 Oct;28(10):2508-13.PMID: 16186288 [PubMed - indexed for MEDLINE]Related articlesFree article

The CHORUS (Cerivastatin in Heart Outcomes in Renal Disease: Understanding Survival) protocol: a double-blind, placebo-controlled trial in patients with esrd.

Keane WF, Brenner BM, Mazzu A, Agro A.

Am J Kidney Dis. 2001 Jan;37(1 Suppl 2):S48-53.PMID: 11158861 [PubMed - indexed for MEDLINE]Related articles

Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.

Pearson T, Denke M, McBride P, Battisti WP, Brady WE, Palmisano J.

Am J Geriatr Pharmacother. 2005 Dec;3(4):218-28.PMID: 16503317 [PubMed - indexed for MEDLINE]Related articles

Inhibition of HMG-CoA reductase with cerivastatin lowers dense low density lipoproteins in patients with elevated fasting glucose, impaired glucose tolerance and type 2 diabetes mellitus.

Scharnagl H, Winkler K, Mantz S, Baumstark MW, Wieland H, März W.

Exp Clin Endocrinol Diabetes. 2004 May;112(5):269-77.PMID: 15146374 [PubMed - indexed for MEDLINE]Related articles

Predictive value of silent myocardial ischemia for cardiac events in diabetic patients: influence of age in a French multicenter study.

Valensi P, Pariès J, Brulport-Cerisier V, Torremocha F, Sachs RN, Vanzetto G, Cosson E, Lormeau B, Attali JR, Maréchaud R, Estour B, Halimi S.

Diabetes Care. 2005 Nov;28(11):2722-7.PMID: 16249546 [PubMed - indexed for MEDLINE]Related articlesFree article

High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial.

Pedersen TR, Faergeman O, Kastelein JJ, Olsson AG, Tikkanen MJ, Holme I, Larsen ML, Bendiksen FS, Lindahl C, Szarek M, Tsai J; Incremental Decrease in End Points Through Aggressive Lipid Lowering (IDEAL) Study Group.

JAMA. 2005 Nov 16;294(19):2437-45. Erratum in: JAMA. 2005 Dec 28;294(24):3092. PMID: 16287954 [PubMed - indexed for MEDLINE]Related articlesFree article

Triple therapy with glimepiride in patients with type 2 diabetes mellitus inadequately controlled by metformin and a thiazolidinedione: results of a 30-week, randomized, double-blind, placebo-controlled, parallel-group study.

Roberts VL, Stewart J, Issa M, Lake B, Melis R.

Clin Ther. 2005 Oct;27(10):1535-47.PMID: 16330290 [PubMed - indexed for MEDLINE]Related articles

Oxidized-LDL levels are changed during short-term serum glucose variations and lowered with statin treatment in early Type 2 diabetes: a study of endothelial function and microalbuminuria.

Paniagua JA, López-Miranda J, Pérez-Martínez P, Marín C, Vida JM, Fuentes F, Fernández de la Puebla RA, Pérez-Jiménez F.

Diabet Med. 2005 Dec;22(12):1647-56.PMID: 16401307 [PubMed - indexed for MEDLINE]Related articles